USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Precision Medicine Applications and Value-based Data Pricing with Pharma and Health-tech to Trigger Market Growth
12-Aug-2020
North America
Market Research
MFA8-01-00-00-00
HC03323-NA-MT_24623
The biobanking ecosystem is witnessing significant transformation. Emergence of one-stop shops and virtual biobanks, rise in services offered to sustain and improve positioning, and precision medicine are characterizing this transformative environment. The biobanking market is expected to reach a size of ~$71.2 billion by 2026, registering a compound annual growth rate (CAGR) of ~5.2% from 2020. While Europe is the highest contributor to the total market, Asia-Pacific (APAC) is expected to witness the highest growth during the forecast period (2020 to 2026) of this research. This market will be driven further by innovation in targeted therapeutic applications, high sample utilization of tissue/stem cells, and the increasing demand for bio-data for enabling patient stratification. Significant growth opportunities for biobanks are in the areas of companion diagnostics (CDx) co-development, large-scale genome sequencing projects, immuno-oncology clinical development, digital pathology services, and real-world evidence (RWE) studies.
The shifting industry paradigm towards commercial partnerships with pharmaceutical and biotech companies, contract research organizations (CROs), and contract development and manufacturing organizations (CDMOs), as well as diagnostics and digital solution providers is expected to further boost market growth. Biobanks are partnering with end-users for customized research-based engagements as niche providers of samples and services and as data owners. However, they need to better understand the changing end-user needs and transition to innovative value-based data pricing and hybrid models for ensuring operational sustainability in the future. Collaborations with commercial partners by fulfilling key selection criteria and engaging with well-defined models are a critical requirement for biobanks to retain market share. A number of leading biobanks in the United States, the United Kingdom, Sweden, and Denmark have taken major strides in adopting and implementing industry best practices in the last few years.
Author: Unmesh Lal
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top Five Strategic Imperatives on the Biobanking Industry
The Impact of the Top Five Strategic Imperatives on the Biobanking Industry (continued)
Growth Opportunities Fuel the Growth Pipeline Engine™
Biobanking Market, Scope of Analysis
Biobanking Market, Scope of Analysis (continued)
Biobanking Market, Scope of Analysis—COVID-19 Impact
Biobanking Market, Scope of Analysis—Key Market Themes
Biobanking Market, Scope of Analysis—Value Chain & Key Stakeholders
Biobanking Market, Scope of Analysis—Workflow Optimization
Biobanking Market, Scope of Analysis—Future Role of Biobanks
Biobanking Market, Scope of Analysis—Future Role of Biobanks (continued)
Biobanking Market, Scope of Analysis—Future Role of Biobanks (continued)
Biobanking Market, Segmentation
Key Competitors and End-users in the Biobanking Market
Key Growth Metrics for the Biobanking Market
Growth Drivers for the Biobanking Market
Growth Driver Analysis for the Biobanking Market
Growth Driver Analysis for the Biobanking Market (continued)
Growth Restraints for the Biobanking Market
Growth Restraint Analysis for the Biobanking Market
Market Forecast Assumptions, Methodology—Biobanking Market
Revenue Forecast, Biobanking Market
Revenue Forecast Analysis by Region, Biobanking Market
Revenue Forecast Analysis by Region, Biobanking Market (continued)
Revenue Forecast Analysis by Region, Biobanking Market (continued)
Revenue Forecast Analysis by Region, Biobanking Market (continued)
Revenue Forecast Analysis by Region, Biobanking Market (continued)
Revenue Forecast Analysis by Region, Biobanking Market (continued)
Revenue Forecast by Application
Percent Revenue Share by Application
Revenue Forecast by Biobank Type
Percent Revenue Share by Biobank Type
Revenue Forecast by Sample Type
Percent Revenue Share by Sample Type
Revenue Forecast by Ownership Type
Percent Revenue Share by Ownership Type
Stakeholder Engagement, Biobanking Market
Pricing Analysis, Biobanking Market
Pricing Analysis, Biobanking Market (continued)
End-user Analysis, Biobanking Market
Competitive Environment, Biobanking Market
Competitive Environment, Biobanking Market (continued)
Competitive Environment, Biobanking Market (continued)
Competitive Environment, Biobanking Market (continued)
Competitive Environment, Biobanking Market (continued)
Top 5 Growth Opportunities
Growth Opportunity 1: Companion Diagnostics Co-Development for Biomarker-based Therapeutics, 2020
Growth Opportunity 1: Companion Diagnostics Co-Development Analysis, 2020
Growth Opportunity 2: Bio-data for Large-scale Genome Sequencing Projects, 2020
Growth Opportunity 2: Large-scale Genome Sequencing Analysis, 2020
Growth Opportunity 3: Human Tissue/Tumor Cells for Oncology Clinical Development, 2020
Growth Opportunity 3: Oncology Clinical Development Analysis, 2020
Growth Opportunity 4: Digital Pathology and Imaging Services, 2020
Growth Opportunity 4: Digital Pathology and Imaging Analysis, 2020
Growth Opportunity 5: RWE Studies for Product Commercialization, 2020
Growth Opportunity 5: RWE Analysis, 2020
Your Next Steps
Why Frost, Why Now?
List of Exhibits
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Unmesh Lal |
| Industries | Healthcare |
| WIP Number | MFA8-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9564-B1,9575-B1,9600-B1,9612-B1,9562-B1,9571-B1,9573-B1,99BC-B1,99C1-B1,99C6-B1,9568-B1,9611-B1,9627-B1 |
Strategic Commercial Partnerships Transforming the Global Biobanking Market, 2020–2026
$4,950.00
Special Price $3,712.50 save 25 %